JavaScript is disabled.
Some features may not work properly. For the best experience, please enable JavaScript in your browser.
Ledgeburg
Sign In
Loading...
News
Latest
Latest News
Stocks
Discover
Search Stocks
ETFs
Discover
Search ETFs
Funds
Discover
Search Funds
CHRS Financials - Coherus Oncology Income & Cash Flow | Ledgeburg
CHRS - Coherus Oncology, Inc.
USD | NASDAQ | Healthcare
Summary
Summary CHRS Stock
Financials
Financials CHRS Stock
Loading...
Loading...
Income Statement
Income Statement CHRS Stock
Balance Sheet
Balance Sheet CHRS Stock
Cash Flow Statement
Cash Flow Statement CHRS Stock
Loading...
Loading...
Home
Stocks
Coherus Oncology, Inc. (CHRS)
Financials
Financials of CHRS
Loading...
Loading...
Loading...
Loading...
Revenue
$42.172M
Operating Income
$-181.134M
Net Income
$168.024M
Share Count (Basic)
117.143457M
Operating Cash Flow
$-138.513M
Free Cash Flow
N/A
Cash And Short-Term Equivalents
$172.125M
Total Debt
N/A
Annual
Quarterly
Revenue $USD
0
100M
200M
300M
FY2021
FY2022
FY2023
FY2024
FY2025
Revenue $USD
0
5M
10M
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26
Annual
Quarterly
Net Income $USD
-300M
-200M
-100M
0
100M
200M
Annual
Quarterly
Margins
Gross
Operating
Net
-800%
-600%
-400%
-200%
0%
200%
400%
FY2021
FY2022
FY2023
FY2024
FY2025
Net Income $USD
-100M
0
100M
200M
300M
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26
FY2021
FY2022
FY2023
FY2024
FY2025
Margins
Gross
Operating
Net
-1000%
0%
1000%
2000%
3000%
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26